Algernon Pharmaceuticals Inc (AGNPF)
0.082
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Algernon Pharmaceuticals Total Assets (Quarterly): 4.912M for Nov. 30, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2022 | 4.912M |
| August 31, 2022 | 6.217M |
| May 31, 2022 | 5.454M |
| February 28, 2022 | 6.101M |
| November 30, 2021 | 6.685M |
| August 31, 2021 | 8.038M |
| May 31, 2021 | 9.625M |
| February 28, 2021 | 8.482M |
| November 30, 2020 | 7.880M |
| August 31, 2020 | 9.802M |
| May 31, 2020 | 10.42M |
| February 29, 2020 | 5.756M |
| November 30, 2019 | 5.124M |
| August 31, 2019 | 3.994M |
| May 31, 2019 | 4.165M |
| Date | Value |
|---|---|
| February 28, 2019 | 4.619M |
| November 30, 2018 | 4.872M |
| August 31, 2018 | 1.096M |
| May 31, 2018 | 1.138M |
| February 28, 2018 | 1.298M |
| November 30, 2017 | 1.120M |
| August 31, 2017 | 1.296M |
| May 31, 2017 | 1.424M |
| February 28, 2017 | 2.038M |
| November 30, 2016 | 2.298M |
| August 31, 2016 | 1.736M |
| May 31, 2016 | 2.015M |
| February 29, 2016 | 1.939M |
| November 30, 2015 | 2.155M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.994M
Minimum
Aug 2019
10.42M
Maximum
May 2020
7.035M
Average
6.451M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 73.30M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.647M |
| Shareholders Equity (Quarterly) | 3.265M |